MedTrace Logo

Patient Reported Outcomes in Chronic Myeloid Leukemia

NCT01252589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 480

Last updated 2016-09-14

No results posted yet for this study

Summary

Although the impact of disease and treatment related burden on health-related quality of life (HRQOL) in patients with solid tumours has been well studied, with several clinical trials that included HRQOL as an endpoint, the general understanding in patients with Chronic Myeloid Leukaemia (CML) is lacking in comparison.

The literature shows that patients' perspective is unique and should always be measured with methodologically sound instruments that are devised for this purpose.

The main scope of this project is develop to an international validated questionnaire for the purpose of HRQOL assessment; such a tool will then be used to provide important data, from the patients' perspective, to make more informed treatment decisions.

Conditions

  • Chronic Myeloid Leukemia

Interventions

OTHER

HRQOL questionnaire

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Fabio Efficace, PhD · GIMEMA DATA CENTER, ROME, ITALY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States
  • Austria
  • Belgium
  • France
  • Germany
  • Greece
  • Iraq
  • Italy
  • Netherlands
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01252589 on ClinicalTrials.gov